Ningbo Tianyi Medical Appliance Co., Ltd. (SHE:301097)
China · Delayed Price · Currency is CNY 55.25
-0.80 (-1.43%)
At close: May 28, 2026
SHE:301097 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 632 | 566.65 | 413.93 | 375.71 | 392.02 | 405.26 |
Other Revenue | 9.11 | 9.11 | 5.03 | 5.21 | 7.31 | 9.47 |
| 641.11 | 575.76 | 418.96 | 380.92 | 399.33 | 414.73 | |
Revenue Growth (YoY) | 52.44% | 37.43% | 9.98% | -4.61% | -3.72% | 9.46% |
Cost of Revenue | 357.67 | 338.09 | 272.79 | 238.63 | 260.4 | 257.24 |
Gross Profit | 283.44 | 237.67 | 146.17 | 142.3 | 138.92 | 157.5 |
Selling, General & Admin | 161.75 | 139.49 | 105.42 | 75.37 | 46.23 | 33.18 |
Research & Development | 57.21 | 56.93 | 60.47 | 31.1 | 28.06 | 20.26 |
Other Operating Expenses | -0.31 | 4.84 | 2.84 | 4.69 | 4.5 | 5.37 |
Operating Expenses | 219.33 | 204.15 | 171.88 | 110.72 | 81.27 | 59.15 |
Operating Income | 64.12 | 33.51 | -25.71 | 31.57 | 57.66 | 98.35 |
Interest Expense | -14.99 | -13.39 | -9.78 | -9.9 | -6.79 | -7.08 |
Interest & Investment Income | 10.62 | 15.05 | 21.43 | 37.18 | 6.55 | 2.49 |
Currency Exchange Gain (Loss) | -13.59 | -13.59 | 6.97 | 4.05 | 26.25 | -7.01 |
Other Non Operating Income (Expenses) | -10.99 | -3.13 | -0.94 | 0.01 | -0.87 | -0.68 |
EBT Excluding Unusual Items | 35.16 | 18.45 | -8.02 | 62.91 | 82.8 | 86.06 |
Gain (Loss) on Sale of Investments | -32.92 | -22.3 | 4.22 | 5.01 | 9.62 | -0.11 |
Gain (Loss) on Sale of Assets | -0 | 0 | -0.22 | -0.05 | -0.22 | 0.81 |
Asset Writedown | -0.11 | -0.11 | -0.08 | -0.06 | -4.79 | -0.82 |
Other Unusual Items | -6.81 | -6.83 | 0.97 | 4.3 | 11.53 | 3.65 |
Pretax Income | -4.68 | -10.78 | -3.14 | 72.1 | 98.94 | 89.6 |
Income Tax Expense | 7.13 | 5.44 | 3.09 | 11.95 | 13.72 | 11.3 |
Earnings From Continuing Operations | -11.8 | -16.22 | -6.22 | 60.15 | 85.22 | 78.29 |
Minority Interest in Earnings | - | - | 5.48 | 3.42 | 0.38 | - |
Net Income | -11.8 | -16.22 | -0.74 | 63.57 | 85.6 | 78.29 |
Net Income to Common | -11.8 | -16.22 | -0.74 | 63.57 | 85.6 | 78.29 |
Net Income Growth | - | - | - | -25.74% | 9.34% | -10.16% |
Shares Outstanding (Basic) | 58 | 58 | 74 | 59 | 55 | 44 |
Shares Outstanding (Diluted) | 58 | 58 | 74 | 59 | 55 | 44 |
Shares Change (YoY) | -22.17% | -22.13% | 26.39% | 6.58% | 24.92% | -0.06% |
EPS (Basic) | -0.20 | -0.28 | -0.01 | 1.08 | 1.55 | 1.77 |
EPS (Diluted) | -0.20 | -0.28 | -0.01 | 1.08 | 1.55 | 1.77 |
EPS Growth | - | - | - | -30.32% | -12.43% | -10.15% |
Free Cash Flow | -280.87 | -210.44 | -48.14 | -148.52 | -98.91 | 66.75 |
Free Cash Flow Per Share | -4.85 | -3.63 | -0.65 | -2.52 | -1.79 | 1.51 |
Dividend Per Share | 0.500 | 0.500 | 0.500 | 0.502 | 0.500 | 0.250 |
Dividend Growth | - | - | -0.32% | 0.32% | 100.00% | - |
Gross Margin | 44.21% | 41.28% | 34.89% | 37.36% | 34.79% | 37.97% |
Operating Margin | 10.00% | 5.82% | -6.14% | 8.29% | 14.44% | 23.71% |
Profit Margin | -1.84% | -2.82% | -0.18% | 16.69% | 21.44% | 18.88% |
Free Cash Flow Margin | -43.81% | -36.55% | -11.49% | -38.99% | -24.77% | 16.09% |
EBITDA | 122.13 | 88.59 | 17.6 | 66.08 | 86.4 | 121.35 |
EBITDA Margin | 19.05% | 15.39% | 4.20% | 17.35% | 21.64% | 29.26% |
D&A For EBITDA | 58.02 | 55.07 | 43.3 | 34.5 | 28.75 | 23 |
EBIT | 64.12 | 33.51 | -25.71 | 31.57 | 57.66 | 98.35 |
EBIT Margin | 10.00% | 5.82% | -6.14% | 8.29% | 14.44% | 23.71% |
Effective Tax Rate | - | - | - | 16.57% | 13.87% | 12.62% |
Revenue as Reported | 641.11 | 575.76 | 418.96 | 380.92 | 399.33 | 414.73 |
Advertising Expenses | - | 3.26 | 2.95 | 4.5 | 1.2 | 1.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.